Clinical Trial

A Comparative Study to Investigate the Difference in Blood Levels of Two Different Formulations of GSK5784283

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to compare how two different formulations of the study medicine (GSK5784283) move through the body over time (pharmacokinetic \[PK\] study) in healthy adults. The aim of the study is to see how the body processes GSK5784283 and determine if the study medicine is safe, how well it is tolerated by the body and if the study medicines being tested work in the body in the same way.
Trial Details
NCT Number NCT07712393
Lead Sponsor GlaxoSmithKline
Conditions Asthma
Enrollment 24 participants
Start Date 2026-07-17
Primary Completion 2027-04-30 (estimated)
Study Completion 2027-05-03 (estimated)
Updated on ClinicalTrials.gov 2026-07-17